Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus. (2018)
Attributed to:
Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2018.01671
PubMed Identifier: 30079068
Publication URI: http://europepmc.org/abstract/MED/30079068
Type: Journal Article/Review
Volume: 9
Parent Publication: Frontiers in immunology
ISSN: 1664-3224